aspirin and tirzepatide In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight Tirzepatide

101(1 Suppl):143S-147S 5

Regulation of the germinal center response

Safety, Skin Sensitivity, and Daily Use Considerations While topical skincare products are generally easy to include in a routine, it is still important to use them thoughtfully

Influence of maternal body mass index on pregnancy complications and outcomes: a systematic review and meta-analysis

Enzymes in the bloodstream degrade it within minutes of release, limiting its therapeutic potential

Greene and Huberman navigate the complexities of modern distractions, including social media, and dissect the contemporary quagmire of gender roles and identity